Clinical Trials Logo

Clinical Trial Summary

Patients who on taking clopidogrel are randomized to either continue clopidogrel into general surgery or discontinue clopidogrel 7 days before surgery. All patients resume clopidogrel after surgery. The investigators track the development of bleeding complications that may develop within 90 days of the surgery. Patients are medically cleared to be in either arm of the study by their cardiologist and surgeon. There is currently no evidence to support for or against the use continuation or discontinuation of clopidogrel prior to general surgery.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic


Related Conditions & MeSH terms


NCT number NCT01960296
Study type Interventional
Source Icahn School of Medicine at Mount Sinai
Contact
Status Completed
Phase Phase 2
Start date January 2012
Completion date May 2013

See also
  Status Clinical Trial Phase
Recruiting NCT03613337 - Effect of Smoking Status and Genetic Risk Factors on Restenosis and Efficacy of Clopidogrel After de Novo Percutaneous Coronary Intervention
Completed NCT01582217 - Patients Undergoing Percutaneous Coronary Intervention (PCI) Through Optimal Platelet Inhibition N/A
Completed NCT02484924 - The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome
Completed NCT04431349 - Comparison of CABG Related Bleeding Complications in Patients Treated With Ticagrelor or Clopidogrel
Completed NCT00753753 - VerifyNow French Registry N/A
Completed NCT05512546 - The Prevention of Thromboembolic Complications Associated With Coil Embolization
Completed NCT01231867 - Cohort Study of Clopidogrel and Proton Pump Inhibitors N/A
Withdrawn NCT00363753 - Pilot Study of Continuing Aspirin Versus Switching to Clopidogrel After Stroke or Transient Ischemic Attack Phase 1
Completed NCT00619073 - PACT (Platelet Activity After Clopidogrel Termination) N/A